The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory

Por Khan, Mohammed I., Sobocińska, Anna A., Czarnecka, Anna M., Król, Magdalena, Botta, Bruno, Szczylik, Cezary
Publicado no Curr Pharm Des (2016)

Involvement of the CB(2) cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma

Por Khan, Mohammed I., Sobocińska, Anna A., Brodaczewska, Klaudia K., Zielniok, Katarzyna, Gajewska, Malgorzata, Kieda, Claudine, Czarnecka, Anna M., Szczylik, Cezary
Publicado no BMC Cancer (2018)